Natco Pharma quarterly results and financials

Natco Pharma (NATCOPHARM)₹804.35−0.09%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Jun 2026 quarter (consolidated), Natco Pharma reported sales of ₹737 Cr, down 44.7% from Jun 2025, and net profit of ₹206 Cr, down 57.1% year on year. For the year to Mar 2026, sales were ₹4,089 Cr and net profit ₹1,414 Cr.

Sales (Jun 2026): ₹737 Cr
Net profit (Jun 2026): ₹206 Cr
Sales (FY Mar 2026): ₹4,089 Cr
Net profit (FY Mar 2026): ₹1,414 Cr
EPS (Jun 2026): ₹11.52
Borrowings (Mar 2026): ₹716 Cr

Company filings, consolidated accounts; latest reported quarter Jun 2026

Natco Pharma quarterly results

₹ crore unless stated; each column is a quarter.

Natco Pharma Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	1,034	761	1,071	1,365	1,375	476	1,224	1,332	1,366	649	741	737
Expenses	571	489	569	556	565	435	671	756	782	487	610	548
Operating Profit	458	268	498	806	805	39.01	548	572	579	159	128	186
OPM %	44.0%	35.0%	47.0%	59.0%	59.0%	8.0%	45.0%	43.0%	42.0%	25.0%	17.0%	25.0%
Other Income	28.99	37.01	42.02	48.01	64.02	176	66.01	62.01	100	58.04	78.08	59.03
Interest	4.01	5.01	6.01	5.01	4.01	4.01	10.02	3.01	13.02	10.03	11.01	13.03
Depreciation	43.87	43.89	55.80	43.85	45.86	46.84	97.70	57.78	51.83	45.83	49.82	46.89
Profit before tax	438	255	476	801	815	163	505	570	612	160	144	185
Tax %	16.0%	17.0%	19.0%	16.9%	16.9%	18.9%	20.0%	15.9%	16.0%	12.9%	−62.1%	34.0%
Net Profit	368	213	385	666	674	132	405	479	517	151	268	206
EPS (Rs)	20.59	11.87	21.55	37.28	37.77	7.42	22.69	26.83	28.91	8.45	14.95	11.52

Natco Pharma profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Natco Pharma Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	1,045	2,024	2,189	2,098	1,918	2,056	1,950	2,715	4,009	4,440	4,089	3,492
Expenses	774	1,334	1,251	1,295	1,328	1,441	1,675	1,767	2,237	2,228	2,633	2,426
Operating Profit	266	684	929	796	584	606	264	936	1,757	2,197	1,438	1,053
OPM %	25.0%	34.0%	42.0%	38.0%	30.0%	30.0%	14.0%	35.0%	44.0%	50.0%	35.0%	30.2%
Other Income	11.99	13.99	40.04	130	107	104	98.97	105	126	354	298	295
Interest	23.06	18.05	15.03	19.05	22.05	13.03	18.04	14.03	19.03	24.05	37.05	47.09
Depreciation	50.87	53.84	65.74	80.72	99.67	117	142	164	186	234	206	194
Profit before tax	203	622	884	822	567	578	201	859	1,669	2,285	1,486	1,102
Tax %	23.9%	21.9%	21.9%	22.0%	19.0%	23.9%	16.0%	17.0%	17.0%	18.0%	8.0%	—
Exceptional items	0.00	0.00	8.01	10.01	13.02	24.03	33.05	14.04	−2.01	1.01	0.00	—
Net Profit	156	484	694	641	457	441	170	713	1,385	1,880	1,414	1,141
EPS (Rs)	9.01	27.84	37.73	35.19	25.30	24.17	9.30	39.14	77.45	105.23	79.17	63.83
Dividend payout %	14.0%	23.9%	21.9%	17.9%	26.9%	21.9%	47.9%	14.0%	11.9%	6.0%	6.0%	—

Natco Pharma balance sheet

₹ crore, at each year end.

Natco Pharma Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	32.99	34.99	34.98	36.97	35.94	35.95	35.99	35.97	35.98	35.96	35.99	36.02
Reserves	814	1,262	1,613	3,033	3,448	3,734	4,085	4,226	4,837	5,815	7,568	9,183
Borrowings	313	113	223	173	387	317	269	417	167	372	280	716
Other Liabilities	225	412	444	468	426	496	403	428	616	679	741	1,137
Total Liabilities	1,385	1,822	2,316	3,711	4,298	4,583	4,793	5,107	5,656	6,902	8,626	11,072
Fixed Assets	712	713	835	1,021	1,231	1,588	2,029	2,318	2,434	2,498	2,706	2,810
CWIP	129	212	336	479	636	517	223	130	63.83	137	225	293
Investments	2.01	22.02	32.05	76.10	169	112	305	308	392	540	475	3,131
Other Assets	541	876	1,112	2,135	2,262	2,365	2,236	2,352	2,766	3,728	5,221	4,838
Inventories	221	358	350	439	530	560	801	763	745	701	767	911
Trade receivables	192	262	474	637	505	550	412	620	855	1,186	1,244	879
Cash & equivalents	12.97	44.86	35.89	183	279	65.82	283	205	544	950	2,170	1,546
Total Assets	1,385	1,822	2,316	3,711	4,298	4,583	4,793	5,107	5,656	6,902	8,626	11,072

Natco Pharma cash flow

₹ crore, for each year.

Natco Pharma Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	92.92	112	346	464	668	417	299	45.96	848	1,211	1,694	1,768
Cash from investing activity	−120	−176	−299	−1,117	−611	−175	−107	4.01	−466	−1,027	−1,437	−2,086
Cash from financing activity	29.13	155	−48.15	653	−51.17	−252	−187	35.12	−365	−248	−212	299
Net cash flow	2.01	90.27	−1.01	−2.01	7.02	−8.02	6.01	85.23	21.08	−62.23	50.13	−16.06
Capex	117	157	280	424	462	359	255	243	206	359	512	391
Free cash flow	−25.06	−44.16	66.21	57.18	226	81.21	92.34	−142	676	857	1,303	1,383
CFO / OP %	54.9%	59.9%	69.0%	72.0%	107.0%	90.0%	71.0%	36.0%	109.9%	85.0%	93.9%	150.9%

Natco Pharma ratios

Working-capital days and returns, by year.

Natco Pharma Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	85	92	86	106	88	105	73	116	115	109	103	79
Inventory days	331	482	213	389	545	534	570	496	432	357	405	480
Days payable	188	371	159	238	223	243	103	104	152	119	144	215
Cash conversion cycle	228	202	138	257	410	395	539	507	394	345	362	343
Working capital days	25	97	71	215	207	295	246	256	198	151	151	163
ROCE %	17.0%	18.1%	39.1%	35.0%	23.1%	14.1%	13.1%	4.0%	18.1%	30.1%	33.1%	17.1%

Natco Pharma: frequently asked questions

What are the latest quarterly results of Natco Pharma?

For the Jun 2026 quarter, Natco Pharma reported sales of ₹737 Cr, down 44.7% year on year and net profit of ₹206 Cr, down 57.1% year on year. The operating margin was 25.0%.

What is the annual revenue of Natco Pharma?

Natco Pharma's sales for the year to Mar 2026 were ₹4,089 Cr; over the last twelve months they were ₹3,492 Cr.

What is the net profit of Natco Pharma?

Net profit for the year to Mar 2026 was ₹1,414 Cr, and ₹1,141 Cr over the last twelve months. Earnings per share over the same trailing period were ₹63.83.

How much debt does Natco Pharma have?

Natco Pharma reported borrowings of ₹716 Cr at Mar 2026, against cash and equivalents of ₹1,546 Cr.

What is the free cash flow of Natco Pharma?

Cash from operations was ₹1,768 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹1,383 Cr.

Loading…